Document is current

Article History

Received: 13 September 2023

Accepted: 4 February 2024

First Online: 16 February 2024

Declarations

:

: The analyses presented in this study were deemed exempt from review by the Tufts Medical Center Institutional Review Board. The research presented in this paper complies with all relevant ethical regulations (Declaration of Helsinki). Only aggregated data from previously conducted clinical trials are presented. The protocol and consent documents of the individual trials used were reviewed and approved by each trial’s participating centers’ institutional review board, and informed consent was provided by all participants of the studies for which results were aggregated for our analyses.

: Not applicable.

: Willem Collier received funding from the National Kidney Foundation for his graduate studies while working on aspects of the submitted work.Benjamin Haaland is a full time employee of Pentara Corporation and consults for the National Kidney Foundation.Hiddo JL Heerspink received grant support from the National Kidney Foundation to his institute and is a consultant for AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, Chinook, CSL Behring, Dimerix, Eli Lilly, Gilead, GoldFinch, Janssen, Merck, Novo Nordisk and Travere Pharmaceuticals.Lesley A Inker reports funding from National Institutes of Health, National Kidney Foundation, Omeros, Chinnocks, and Reata Pharmaceuticals for research and contracts to Tufts Medical Center; consulting agreements to Tufts Medical Center with Tricida; and consulting agreements with Diamerix.Tom Greene reports grant support from the National Kidney Foundation, Janssen Pharmaceuticals, Durect Corporation and Pfizer and statistical consulting from AstraZeneca, CSL and Boehringer Ingleheim.